TY - JOUR
T1 - Role of Glucagon in Diabetes
AU - Unger, Roger H
AU - Orci, L.
PY - 1977/4
Y1 - 1977/4
N2 - The glucagon-secreting A cell is a vital component of the organ system which regulates the distribution of fuel— the islets of Langerhans. Bihormonal control of glucoregulation through a push-pull system maintains the glucose concentration of extracellular fluid within narrow limits irrespective of glucose flux rates through relative equality of glucose influx and efflux. This equality requires appropriate secretion mixtures of the biologic antagonists, insulin and glucagon, directed by a glucose sensor. In severe diabetes, there are virtually no B cells and A cells are in contact largely with other A cells and their glucose-sensing capacity is lost. The A cell hypersecretes and in most juvenile type diabetics aggressive therapy with insulin fails to restore it to normal. Glucagon is a factor in the development of endogenous hyperglycemia, and ketoacidosis. Its suppression may provide a possible approach in the future pharmacologic management of diabetic hyperglycemia.
AB - The glucagon-secreting A cell is a vital component of the organ system which regulates the distribution of fuel— the islets of Langerhans. Bihormonal control of glucoregulation through a push-pull system maintains the glucose concentration of extracellular fluid within narrow limits irrespective of glucose flux rates through relative equality of glucose influx and efflux. This equality requires appropriate secretion mixtures of the biologic antagonists, insulin and glucagon, directed by a glucose sensor. In severe diabetes, there are virtually no B cells and A cells are in contact largely with other A cells and their glucose-sensing capacity is lost. The A cell hypersecretes and in most juvenile type diabetics aggressive therapy with insulin fails to restore it to normal. Glucagon is a factor in the development of endogenous hyperglycemia, and ketoacidosis. Its suppression may provide a possible approach in the future pharmacologic management of diabetic hyperglycemia.
UR - http://www.scopus.com/inward/record.url?scp=0017564902&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0017564902&partnerID=8YFLogxK
U2 - 10.1001/archinte.1977.03630160050012
DO - 10.1001/archinte.1977.03630160050012
M3 - Article
C2 - 403869
AN - SCOPUS:0017564902
SN - 2168-6106
VL - 137
SP - 482
EP - 491
JO - Archives of internal medicine (Chicago, Ill. : 1908)
JF - Archives of internal medicine (Chicago, Ill. : 1908)
IS - 4
ER -